CN Patent

CN108601745A — 口服考来烯胺制剂及其用途

Assigned to Albireo AB · Expires 2018-09-28 · 8y expired

What this patent protects

本发明涉及用于将考来烯胺靶向递送至结肠的口服制剂，其包含用扩散‑控制的内包衣和肠溶外包衣涂覆的多个考来烯胺丸剂。本发明还涉及该制剂治疗胆汁酸吸收不良的用途。

USPTO Abstract

本发明涉及用于将考来烯胺靶向递送至结肠的口服制剂，其包含用扩散‑控制的内包衣和肠溶外包衣涂覆的多个考来烯胺丸剂。本发明还涉及该制剂治疗胆汁酸吸收不良的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN108601745A
Jurisdiction
CN
Classification
—
Expires
2018-09-28
Drug substance claim
No
Drug product claim
No
Assignee
Albireo AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.